ARTICLE | Company News
Alltracel, HemCon deal
May 19, 2008 7:00 AM UTC
Medical device company HemCon completed its previously announced acquisition of Alltracel for 14p per share, or £20.8 million ($40.6 million) in cash (see BioCentury, March 3). ...